State of Tennessee Treasury Department continued to hold its position in shares of Steris Plc (NYSE:STE) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,000 shares of the company’s stock at the end of the third quarter. State of Tennessee Treasury Department’s holdings in Steris Plc were worth $2,193,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in STE. Bronfman E.L. Rothschild L.P. boosted its position in shares of Steris Plc by 26.3% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 1,528 shares of the company’s stock valued at $112,000 after buying an additional 318 shares in the last quarter. Amica Retiree Medical Trust bought a new position in shares of Steris Plc during the third quarter valued at about $119,000. Creative Planning boosted its position in shares of Steris Plc by 76.9% in the third quarter. Creative Planning now owns 1,838 shares of the company’s stock valued at $134,000 after buying an additional 799 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Steris Plc by 85.8% in the second quarter. Bessemer Group Inc. now owns 1,942 shares of the company’s stock valued at $134,000 after buying an additional 897 shares in the last quarter. Finally, Prentiss Smith & Co. Inc. bought a new position in shares of Steris Plc during the third quarter valued at about $188,000. Institutional investors own 91.50% of the company’s stock.

Institutional Ownership by Quarter for Steris Plc (NYSE:STE)

Shares of Steris Plc (NYSE:STE) traded up 0.99% during trading on Friday, hitting $69.18. 154,410 shares of the company traded hands. The company has a 50 day moving average price of $67.86 and a 200 day moving average price of $69.12. The company has a market capitalization of $5.89 billion, a price-to-earnings ratio of 34.92 and a beta of 1.27. Steris Plc has a 52 week low of $61.38 and a 52 week high of $74.63.

Steris Plc (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported $0.89 earnings per share for the quarter, missing analysts’ consensus estimates of $0.90 by $0.01. Steris Plc had a net margin of 6.41% and a return on equity of 9.89%. The company had revenue of $646.40 million for the quarter, compared to the consensus estimate of $670.24 million. During the same quarter in the previous year, the business earned $0.83 EPS. The company’s quarterly revenue was up 31.9% compared to the same quarter last year. On average, analysts expect that Steris Plc will post $3.89 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 21st. Investors of record on Wednesday, November 23rd were issued a dividend of $0.28 per share. The ex-dividend date of this dividend was Monday, November 21st. This represents a $1.12 dividend on an annualized basis and a yield of 1.64%. Steris Plc’s payout ratio is 57.14%.

WARNING: “Steris Plc (STE) Stake Maintained by State of Tennessee Treasury Department” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another website, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be accessed at http://www.watchlistnews.com/steris-plc-ste-stake-maintained-by-state-of-tennessee-treasury-department/1060470.html.

Several equities analysts recently issued reports on the stock. JMP Securities reiterated a “buy” rating on shares of Steris Plc in a research report on Friday, November 4th. Zacks Investment Research upgraded shares of Steris Plc from a “sell” rating to a “hold” rating in a research report on Wednesday, December 7th. Finally, Goldman Sachs Group, Inc. (The) assumed coverage on shares of Steris Plc in a research report on Wednesday, November 30th. They set a “neutral” rating and a $71.00 price target on the stock.

In other Steris Plc news, VP John Adam Zangerle sold 2,200 shares of the firm’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $67.00, for a total transaction of $147,400.00. Following the transaction, the vice president now owns 26,166 shares of the company’s stock, valued at approximately $1,753,122. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel A. Carestio sold 2,225 shares of the firm’s stock in a transaction dated Thursday, December 8th. The shares were sold at an average price of $67.54, for a total transaction of $150,276.50. Following the transaction, the insider now directly owns 20,025 shares in the company, valued at approximately $1,352,488.50. The disclosure for this sale can be found here. Corporate insiders own 2.52% of the company’s stock.

About Steris Plc

STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.

5 Day Chart for NYSE:STE

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.